Maximizing Endoscopic Video Interpretation for Inflammatory Bowel Disease
The Problem
There is an unmet need for precision disease assessment for IBD patients.
Colonoscopy
is the Best Biomarker for Assessment of IBD
Colonoscopy
is the Best Biomarker for Assessment of IBD
HOWEVER
Interpretation is Subjective
HOWEVER
Interpretation is Subjective
FURTHERMORE
Conventional Metrics Poorly Quantify Disease Distribution and BurdenFURTHERMORE
Conventional Metrics Poorly Quantify Disease Distribution and Burden
What We Do
Endoscopic Disease Assessment for IBD Patients
(using AI/ML)
Input Colonoscopy Video Frames
Signal Processing & AI/ML Models
Signal Processing & AI/ML Models
Disease Severity & Distribution
Our Impact / Value Proposition
Pharma / CROs
- Increase visibility on therapeutic effect
- Accelerate time to market
Payors
- Reduce over / under prescription of drugs
- Improve outcomes at lower cost
Providers
- Demonstrate quality to payors
- Clinical decision support
- Expedite treatment authorization
Patients
- Expand access to underserved populations
- Improve outcomes
Product / Technology
Technology Developed by Gastroenterologists & Leading AI Experts
- Licensed by University of Michigan to PathwaysGI
Developed & Validated Using
- Real World Clinical Evidence
- Randomized Clinical Trials
- Global Endoscopic Video Data